Usability Study of IeHS in Indonesia

NCT04179344 | Completed

• 1 other identifier: IeHS_Indonesia
• Study Type: observational
• Target: 25
• Locations: 1 country
• Sites: 3

Brief Summary

Technology that has a particular focus on patients' needs and ease-of-use and -access plays a significant role in the development of e-health and m-health. The proposed model of a secured mobile health application may promote patient's self-management and enhances adherence in chronic therapy exactly as it is easy-to-use, reducing patient's burden in accessing medication information and instructions, and providing the opportunity for direct communications with health providers in charge for each patient with access to mobile technologies. Consequently, medication errors and unnecessary paperwork in the healthcare system will be avoided as well as giving more time for healthcare providers to pay greater attention to delivering medical care effectively and efficiently.

Conditions

Human Immunodeficiency Virus; Tuberculosis; Interpersonal Relations; Mobile Phone Use; Adult

Keywords

Pharmaceutical care; HIV; TB; Internet; Surveys and questionnaires; Humans; Pharmacovigilance

Outcome Measures

Primary Outcomes (4)

• Tasks completion success

  Effectiveness is defined by task completion success numbers of errors occur during the web-app simulation

  during the simulation for each participant in 3 months of study period

• Numbers of tasks errors

  Effectiveness is defined by task completion success numbers of errors occur during the web-app simulation

  during the simulation for each participant in 3 months of study period

• Average time to complete each task

  Efficiency is defined as level of efforts use by the study participant to complete the web-app simulation each task.

  during the simulation for each participant in 3 months of study period

• system usability scale (SUS) score

  IeHS satisfaction is defined through the SUS questionnaire which allows measurements of overall usability, allowing comparisons across a range of contexts and systems. SUS score is ranged from 0 (worst) to 100 (perfect).

  after half-an-hour of the web-app simulation during 3 months of study period

Secondary Outcomes (1)

• Participant experience using the IeHS web-based app

  half an hour after web-based app simulation during 3 months of study period

Study Arms (1)

Integrated e-healthcare services (IeHS) web-based app

This usability study is conducted under 3 steps: IeHS simulation, user experience survey using SUS questionnaire, and qualitative study through the in-depth interview.

Other: Integrated e-healthcare services (IeHS) web-based app

Interventions

Integrated e-healthcare services (IeHS) web-based app OTHER

Each participant is asked to complete study tasks using the IeHS web-based app as a part of IeHS simulation. This activity is followed by user experience survey, and an in-depth interview to explore user satisfaction on the IeHS web-based app

Integrated e-healthcare services (IeHS) web-based app

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults males or females involved in HIV and TB treatment, i.e. physicians, pharmacists, HIV and/or TB patients.

You may qualify if:

• Males or females age 18 years old or more;
• Acting as one of the following users: pulmonologist, internist, GP, pharmacists, and a patient who suffers from TB and/or HIV;
• In case of a patient user: on drug treatment;
• Use a smartphone and know how to use it;
• Familiar with technology, particularly ICT;
• Understand basic english;
• Able to speak and communicate in Bahasa Indonesia;
• Willing to participate and sign informed consent.

You may not qualify if:

• A severe clinical condition that might impair the hearing or the seeing;
• Unwillingness to participate.

Sponsors & Collaborators

• Bekasi City Public Hospital: lead
• University of Groningen: collaborator

Study Sites (3)

Bekasi public hospital

Bekasi, West Java, 17132, Indonesia

Location

Padang

Padang, West Sumatra, 25111, Indonesia

Location

Jakarta

Jakarta, 10110, Indonesia

Location

Related Publications (8)

• GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2018 Mar;18(3):261-284. doi: 10.1016/S1473-3099(17)30703-X. Epub 2017 Dec 7.

  PMID: 29223583 BACKGROUND

• Marais BJ, Lonnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013 May;13(5):436-48. doi: 10.1016/S1473-3099(13)70015-X. Epub 2013 Mar 24.

  PMID: 23531392 BACKGROUND

• Glaziou P, Floyd K, Raviglione MC. Global Epidemiology of Tuberculosis. Semin Respir Crit Care Med. 2018 Jun;39(3):271-285. doi: 10.1055/s-0038-1651492. Epub 2018 Aug 2.

  PMID: 30071543 BACKGROUND

• Podlekareva DN, Panteleev AM, Grint D, Post FA, Miro JM, Bruyand M, Furrer H, Obel N, Girardi E, Vasilenko A, Losso MH, Arenas-Pinto A, Cayla J, Rakhmanova A, Zeltina I, Werlinrud AM, Lundgren JD, Mocroft A, Kirk O; HIV/TB study group. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe. Eur Respir J. 2014 Jan;43(1):166-77. doi: 10.1183/09031936.00138712. Epub 2013 Jun 13.

  PMID: 23766333 BACKGROUND

• WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update. Geneva: World Health Organization; 2016. Available from http://www.ncbi.nlm.nih.gov/books/NBK390455/

  PMID: 27748093 BACKGROUND

• Workneh MH, Bjune GA, Yimer SA. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia. Infect Dis Poverty. 2016 Mar 21;5:22. doi: 10.1186/s40249-016-0115-z.

  PMID: 27009088 BACKGROUND

• Free C, Phillips G, Watson L, Galli L, Felix L, Edwards P, Patel V, Haines A. The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Med. 2013;10(1):e1001363. doi: 10.1371/journal.pmed.1001363. Epub 2013 Jan 15.

  PMID: 23458994 BACKGROUND

• Patel AR, Kessler J, Braithwaite RS, Nucifora KA, Thirumurthy H, Zhou Q, Lester RT, Marra CA. Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya. Medicine (Baltimore). 2017 Feb;96(7):e6078. doi: 10.1097/MD.0000000000006078.

  PMID: 28207516 BACKGROUND

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome; Tuberculosis; Cell Phone Use

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases; Mycobacterium Infections; Actinomycetales Infections; Gram-Positive Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Communication; Behavior; Social Behavior

Study Officials

• Lusiana R Idrus, Master

  Bekasi City Public Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Pharmacist

Study Record Dates

• First Submitted: August 1, 2019
• First Posted: November 27, 2019
• Study Start: August 5, 2019
• Primary Completion: October 31, 2019
• Study Completion: October 31, 2019
• Last Updated: November 27, 2019

Record last verified: 2019-11

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
• Time Frame: November 2019 and will become available until publication
• Access Criteria: Only for investigators

Locations

ID (3)